Primary record
(4S)-4-Ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3 inverted exclamation marka,4 inverted exclamation marka:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 库存
- 7,881 克
- 纯度
- 99.5 %
- CAS
- 203923-89-1
化合物标识与属性
- CAS
- 203923-89-1
- PubChem CID
- 148202
- SMILES
- CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CC[Si](C)(C)C)O
- Canonical SMILES
- CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CC[Si](C)(C)C
名称与同义词
- Karenitecin
- Cositecan
- Karentecin
- cositecanum
- 203923-89-1
- Karenitecin (TN)
- Cositecan [USAN]
- Karenitecin (Cositecan)
- Cositecan (USAN)
- BNP1350
- Cositecan;BNP 1350
- Cositecan [USAN:INN]
- COSITECAN [INN]
- COSITECAN [MI]
- UNII-24R60NVC41
- BNP-1350
- RefChem:128190
- D02CZK
- AC1L3WN8
- COSITECAN [WHO-DD]
- 24R60NVC41
- BNP 1350
- C25H28N2O4Si
- DTXSID90174340
- DB 172
- orb1707518
- SCHEMBL2315201
- 7-Trimethylsilylethylcamptothecin
- CHEMBL1997373
- DTXCID2096831
- SCHEMBL15419296
- SCHEMBL29378211
- CHEBI:177492
- NSC710270
- POADTFBBIXOWFJ-VWLOTQADSA-N
- C25-H28-N2-O4-Si
- CID148202
- AKOS040741401
- ZINC169746728
- ACN-035786
- DB05806
- NSC-710270
- 7-[2-(trimethylsilyl)ethyl]camptothecin
- AN-29989
- HY-14812
- MS-28131
- NCI60_038797
- CS-0003573
- NS00073515
- J1.562.147H
- D09327
- G13583
- Z-3161
- 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-, (4S)-
- 923K891
- A1006748
- Q27095699
- (19S)-19-ethyl-19-hydroxy-10-(2-trimethylsilylethyl)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- (4S)-4-Ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione
- (S)-4-ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
- (S)-4-ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione.
- (19S)-19-ethyl-19-hydroxy-10-(2-(trimethylsilyl)ethyl)-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.0?,?.01?,2?)henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- (19S)-19-ethyl-19-hydroxy-10-[2-(trimethylsilyl)ethyl]-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
- (4S)-4-ETHYL-4-HYDROXY-11-(2-(TRIMETHYLSILYL)ETHYL)-1,12-DIHYDRO-14H- PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H)-DIONE
- (4S)-4-Ethyl-4-hydroxy-11-(2-trimethylsilyl)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4-Ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3 inverted exclamation marka,4 inverted exclamation marka:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- (4S)-4-Ethyl-4beta-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
- 1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4-ETHYL-4-HYDROXY- 11-(2- (TRIMETHYLSILYL)ETHYL)-, (4S)-
- 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-(2-trimethylsilyl)ethyl)-, (4S)-